FDA Inspection
Cadila Pharmaceuticals LimitedCadila Pharmaceuticals Limited – FDA Inspection, Jul 25, 2016
Record Details
This FDA Inspection record concerns Cadila Pharmaceuticals Limited, with an inspection on July 25, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 25, 2016
- Product Type
- Drugs
View Company Profile
ID · 1dee8c78-60d2-4392-b9a9-fa0a0d0b3ec7
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 982066
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Cadila Pharmaceuticals Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 10, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 9, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 28, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 11, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cadila Pharmaceuticals Limited
- FDA Inspection 1239090 - 2024-05-10
- FDA Inspection 1102381 - 2019-08-09
- FDA Inspection 1044877 - 2018-02-13
- FDA Inspection 873262 - 2014-03-28
- FDA Inspection 664596 - 2009-12-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.